Wells Fargo raises Veeva Systems stock price target on AI growth

Wells Fargo raised its price target on Veeva Systems (VEEV) to $400 from $330, citing AI-driven growth. The stock trades at $305.55, with a 31% upside to the new target. Analysts project $1B in AI revenue by 2030, separate from its $6B core business. VEEV's revenue grew 16.5% over the last year, with strong profit margins. Multiple analysts have raised their price targets, reflecting optimism about Veeva's AI and cloud growth prospects.

Original reporting
Published Nov 11, 2026, 10:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 10:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VEEV
Bullish
high confidence
Mentioned
$VEEV
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$VEEVBullishHigh
01

Why it matters

Collective analyst upgrades could drive short‑term buying interest.

02

Market read

Analyst upgrades suggest near‑term upside for VEEV, with broader AI software sector benefit.

03

What to watch

Potential slowdown in AI adoption or competitive pressure from larger cloud providers.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Multiple brokerages (BMO, Truist, BTIG, Mizuho, Oppenheimer) also raised Veeva price targets, reinforcing the bullish outlook.

Company-level read

Ticker impact

$VEEVBullishHigh confidence
Context

Wells Fargo raised its price target on Veeva Systems to $400 from $330, indicating fresh bullish analyst coverage.

Expected impact

likely upward pressure as investors price in the new target.

Evidence & confidence

The upgrade is a primary disclosure with a sizable target increase for a mid‑cap company.

Market effects

Strengthens AI‑focused cloud software sector sentiment.

U.S. tech equities may see modest lift.

Limited to investors tracking AI software stocks.

Counterpoint

Target may be overly optimistic given execution risk of AI revenue goals.

Key entities

  • Wells Fargo

    Raised Veeva target to $400.

  • Veeva Systems

    AI‑focused cloud software provider.

Related articles

$VEEVHigh

VEEVA SYSTEMS INC (VEEV): Total Revenue $932-935 million Subscription Revenue ~$782 million Services Revenue $150-153 million Non-GAAP Operating Income $417-420 million Non-GAAP Fully…

VEEVA SYSTEMS INC (VEEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Total Revenue $932-935 million Subscription Revenue ~$782 million Services Revenue $150-153 million Non-GAAP Operating Income $417-420 million Non-GAAP Fully Diluted Net Income per Share $2.33-2.34 Expect to Meet or Exceed Q3’27 Guidance Guidance issued on August 26, 2026. Our Q3

$VEEVHigh

Veeva Systems (VEEV) Stock Trades Up, Here Is Why

Veeva Systems (VEEV) stock rose 2.8% after expanding its partnership with IQVIA, which adopted Veeva's clinical operations software. The company reported Q2 revenue of $928M, up 17.6% YoY, beating estimates. VEEV raised full-year revenue guidance to $3.68B and adjusted earnings outlook to $9.21 per share. The stock is up 37% YTD and hit a 52-week high.

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.